Tenth of the "ASCO Direct™ China" webinar series: Immunotherapy for Advanced Gastric Cancer

About this Event

Webinar Date:

  • China Time: Sunday, September 13th, 9:00AM
  • US EST Time: Saturday, September 12th, 9:00PM
  • US PST Time: Saturday, September 12th, 6:00PM

Conference Language: English

Venue: Live Zoom Webinar

Webinar Agenda

US and Chinese Co-Chairs Introduction:

  • Prof. George Fisher, Medical Oncology, Stanford University
  • Prof. Lin Shen, Peking University Cancer Hospital

Presentations:

Results of Tislelizumab Phase II Clinical Trial: Combination With Chemotherapy as First-Line Treatment for HER2 negative local advanced metastatic gastric or gastroesophageal junction cancer (GC/GEJC)

  • Prof. Miaozhen Qiu, Sun Yat-sen University Cancer Hospital

Pembrolizumab versus paclitaxel for previously treated patients with PD-L1–positive advanced gastric or gastroesophageal junction cancer (GC): Update from the phase III KEYNOTE-061 trial

  • Prof. George Fisher, Medical Oncology, Stanford University

Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2− advanced gastric or gastroesophageal junction cancer (GC/GEJC)

  • Prof. Narikazu Boku, National Cancer Center Hospital

Research progress of immunotherapy in advanced gastric cancer

  • Prof. Lian Liu, Qilu Hospital

Panel Discussion

Chairs:

  • Dr. George Fisher, Professor of Medical Oncology, Stanford University
  • Prof. Lin Shen, Peking University Cancer Hospital

Guests:

  • Prof. Narikazu Boku, National Cancer Center Hospital
  • Prof. Xiaotian Zhang, Peking University Cancer Hospital
  • Prof. Jun Zhang, Ruijin Hospital Affiliated to Shanghai NO.2 Medical University
  • Prof. Lian Liu, Qilu Hospital
  • Prof. Miaozhen Qiu, Sun Yat-sen University Cancer Hospital

Speakers and Panelists Bio

                    

Prof. George Fisher, Professor of Medical Oncology, Stanford University

Dr. George Fisher is a Professor of Medical Oncology at Stanford University where he specializes in gastrointestinal cancers. He received his PhD in Cancer Biology and did all of his medical training at Stanford. Dr. Fisher is co-chair of the GI Committee for ECOG-ACRIN and serves on the NCI GI Steering Committee which is responsible for approving all randomized GI cancer trials within the National Cancer Trials Network (NCTN). His primary interest is in the design and conduct of therapeutic trials but he also collaborates with colleague in molecular biomarker and imaging research.

                   

Prof. Lin Shen, Peking University Cancer Hospital

  • Chief physician, Doctoral Supervisor
  • Vice President, Director of Department of Gastrointestinal Medical Oncology and Phase I Clinical Ward
  • Chairman of Oncology Drug Clinical Trial Professional Committee, Chinese Anti Cancer Association
  • Chairman of Chinese College of Surgeons MDT Professional Committee
  • Secretary General of Chinese Gastric Cancer Association, Vice Chairman of the Colorectal Cancer Professional Committee
  • Vice group leader of colorectal and gastrointestinal group, Oncology Branch, Chinese Medical Association
  • Chairman of CSCO Gastrointestinal Stromal Tumor Professional Committee, Alternate chairman of Gastric Cancer Professional Committee

                      

Prof. Miaozhen Qiu, Sun Yat-sen University Cancer Hospital

  • Associate Chief Physician and Doctoral Supervisor, Department of Internal Medicine, Sun Yat-sen University Cancer Hospital
  • Postdoctor, Johns Hopkins University, USA
  • 2018 ESMO Merit Award Recipient
  • 2017 American and Chinese Anti-Cancer Association & Asian Cancer Research Fund recipient
  • Outstanding Young Talents and Clinical Scientist of Sun Yat-sen University Cancer Hospital
  • Head of the Youth Fund of the National Natural Science Foundation of China and the Scientific Research Fund of the Health Department of Guangdong Province
  • Member of CSCO Gastric Cancer Expert Committee and Pancreatic Cancer Youth Committee
  • Youth Committee Member of Gastric Cancer Professional Committee, Chinese Anti-Cancer Association
  • Member of Youth Committee of Gastric Cancer Professional Committee of Guangdong Anti-cancer Association
  • Member of Youth Committee of Digestive Tract Oncology Branch, Guangdong Medical Association
  • Standing Committee Member of the First Professional Committee of Colorectal Cancer, Guangzhou Anti-cancer Association
  • Published more than 40 SCI articles as the first author/co-first author in journals such as IJC and BJC

                       

Prof. Narikazu Boku, National Cancer Center Hospital

  • 1987 - 1988 Resident, Dept. of Internal Medicine, Tokyo University Hospital
  • 1988 - 1989 Resident, Dept. of Internal Medicine, Central Hospital of Social Health Insurance
  • 1989 - 1990 Trainee, Div. of Digestive Endoscopy, National Cancer Center Hospital
  • 1990 - 1991 Research Fellow, Institute of Molecular and Cellular Biosciences, University of Tokyo
  • 1991 - 1992 Staff, Dept. of Internal Medicine National Matsudo Hospital
  • 1992 - 2002 Staff, Div. of Gastrointestinal Oncology, National Cancer Center Hospital East
  • 2002 - 2010 Chief of Div. of Gastrointestinal Oncology, Shizuoka Cancer Center
  • 2010 - 2014 Professor, Dept. of Clinical Oncology, St. Marianna University School of Medicine
  • 2014 – Present Chief, Div. of Gastrointestinal Medical Oncology, National Cancer Center Hospital
  • 2015 – Present Deputy Director for Development and Planning, National Cancer Center Hospital                            

 

                     

Prof. Lian Liu, Qilu Hospital

  • Doctor of Oncology, Postdoctor of Immunology and Doctoral Supervisor in Shandong University
  • Chairman of the Professional Committee on Tumor Molecular Markers and Targeted Therapy, Shandong Society of Immunology
  • Member of Immunotherapy Expert Committee of the Chinese Society of Clinical Oncology (CSCO)
  • Member of CSCO Thyroid Cancer Expert Committee
  • Member of CSCO tumor nutrition treatment expert committee
  • Member of Internal Medicine Group of Professional Committee on Gastric Cancer, Chinese Anti-Cancer Association (CGCA)
  • Member of youth Committee of Cancer Branch, Chinese Medical Doctors Association
  • Vice Chairman of Youth Committee of Shandong Medical Association Palliative Medicine Branch
  • Member of Shandong Anti cancer Association Chemotherapy Branch and Standing Committee Member of Youth Committee
  • Vice Chairman of Specialized Committee of Integrative Oncology, Shandong Pain Medical Association
  • SCI articles as the first author/co-first author in journals such as IJC and BJC

                      

Prof. Xiaotian Zhang, Peking University Cancer Hospital

  • M.D., Chief Physician, Associate Professor, Master Supervisor;
  • Deputy Director of Department of Gastrointestinal Medical Oncology and International Cooperation and Exchange Department, Peking University Cancer Hospital;
  • Executive Deputy Director of Internal Medicine Teaching and Research Office
  • Chairman of Youth Expert Committee of Chinese Society of Clinical Oncology
  • Member of Executive Committee of Chinese Society of Clinical Oncology
  • Member of Gastric Cancer Committee, Chinese Anti-Cancer Association
  • Secretary General of Tumor Nutrition Therapy and Support Committee of Chinese Anti-Cancer Association, Group Leader of Chemotherapy Nutrition Group
  • Standing member of gastrointestinal sub committee of geriatric oncology Committee of Chinese Geriatric Society
  • Member of Evidence-based Medicine Group of the Sixth Committee of Clinical Epidemiology Branch, Chinese Medical Association
  • Reviewer Experts in Journal of Clinical Oncology, Chinese Journal of Oncology and Chinese Medical Journal, Editorial Board of Chinese Journal of Clinical Nutrition and Chinese Journal of PLA Medicine; Responsible for more than ten phase II and III international multicenter clinical studies and a number of domestic phase II and III clinical studies; Published more than ten SCI articles and dozens of core journals; Participated in the compilation of monograph "Advanced Tutorial in Oncology", etc.

                       

Prof. Jun Zhang, Ruijin Hospital Affiliated to Shanghai NO.2 Medical University

  • Director of Department of Oncology, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine
  • Research Fellow, Shanghai Institute of Digestive Surgery
  • Leading Medical Talents in Shanghai
  • Outstanding Academic Leaders in Shanghai
  • Vice Group Leader of Gastric Cancer Group, Chinese Medical Association Oncology Branch
  • Vice Chairman of Youth Committee of Cancer Branch, Chinese Medical Doctors Association
  • Vice Chairman of Professional Committee of Tumor Support, Chinese Anti-Cancer Association
  • Vice Chairman of Youth Committee of Chinese Society of Clinical Oncology
  • Standing Committee Member, Professional Committee of Gastric Cancer, Chinese Anti-Cancer Association
  • Vice Chairman of Precision Medicine and MDT Professional Committee, Chinese Research Hospital Association
  • Vice President of Oncology Branch of Shanghai Medical Doctor Association
  • Alternate Chairman of Professional Committee of Tumor Target Molecules, Shanghai Medical Association

____________________________________________________________________________

Immunotherapy for Advanced Gastric Cancer

Abstract #: 315

Association between immune and tumor gene signatures with response or resistance to tislelizumab monotherapy or in combination with chemotherapy in gastroesophageal adenocarcinoma

Abstract #: 4503

Pembrolizumab versus paclitaxel for previously treated patients with PD-L1–positive advanced gastric or gastroesophageal junction cancer (GC): Update from the phase III KEYNOTE-061 trial

Abstract #: 278

Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2− advanced gastric or gastroesophageal junction cancer (GC/GEJC)


If you need to request a copy of the abstract, please send email to "webinars@eChinaHealth.com”.

Disclaimers: ASCO and eChinaHealth do not endorse any health care product, therapy, diagnostic test or device.

          

Organizer:            

                           

Partner:

                                             

Exclusive Live Streaming Platform:

                                                   

Welcome

Welcome to john the ASCO China Conference WeChat Groups! You can follow up the latest on ASCO China conferences and network with fellow Chinese and global attendees. We will post the conference information including the links on recorded conference videos. Please use your WeChat to scan the QR code to join.